Abstract
This work presents the first multicentric, single
arm, prospective study to evaluate the ability of MammoWave,
a microwave imaging prototype, in breast lesions detection.
This study was the first breast microwave imaging study
during which both symptomatic and asymptomatic subjects
were recruited. MammoWave output consists of a selection of
microwave images’ features, determined prior to the beginning
of the trials, to quantify images’ non-homogenous behavior.
Our results on 382 breasts show a sensitivity of 82% using a
statistical significance of p<0.05, indicating MammoWave’s
ability in distinguishing breasts with and without radiological findings. This prospective clinical trial may pave the way for introducing microwave imaging into clinical practice, for assisting in identification of breast lesions in asymptomatic women of all ages, without safety limitations.
Original language | English |
---|---|
Publication status | Published - 26 May 2023 |
Event | EUCAP 23 - Florence, Italy Duration: 26 Mar 2023 → 31 Mar 2023 https://www.eucap2023.org/ |
Conference
Conference | EUCAP 23 |
---|---|
Country/Territory | Italy |
City | Florence |
Period | 26/03/23 → 31/03/23 |
Other | The 17th European Conference on Antennas and Propagation |
Internet address |